| Particulars |
|
|
|
| Company Name
| Venmax Drugs & Pharmaceuticals Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
5.24 |
B.V. (₹) |
8.40 |
| Sales(₹ Cr.) |
0.81 |
NP (₹ Cr.) |
-0.01 |
| NP Var (%) |
-116.00 |
Div% |
0.00 |
| CPS(₹) |
0.00 |
EPS (₹) |
0.00 |
| Traded Value(₹ Lakhs) |
5.54 |
52 Week High |
32.00 |
| 52 Week Low |
6.00 |
Price BSE |
29.00 |
| Price NSE |
0.00 |
Market Capital (₹ Cr.) |
15.25 |
| P/C Ratio |
-3,706.30 |
P/E Ratio |
-1,447.20 |
| Price Vs.BV |
3.45 |
|
| Latest Quarter |
| Year End |
202506 |
Sales (₹ Cr.) |
1.21 |
| NP(₹ Cr.) |
0.04 |
NP Var % |
246.00 |
| Trailing Twelve Months |
| Year End |
202506 |
Sales |
0.28 |
| OPM |
-133.37 |
NP |
-0.22 |
| NP Var (%) |
-72.08 |
EPS |
0.03 |
| PE |
0.00 |
|
|